Flomic Global Logistics (BSE 504380)₹48.00+2.24%Logistics Solution Provider
At the end of the Jun 2026 quarter, Flomic Global Logistics' shareholders were: promoters 69.18%, public 30.82%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 5,847 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27.48% | 26.44% | 26.33% | 26.33% | 26.33% | 26.33% | 69.16% | 69.16% | 69.16% | 69.16% | 69.18% | 69.18% |
| Public | 72.52% | 73.56% | 73.67% | 73.67% | 73.67% | 73.67% | 30.84% | 30.84% | 30.84% | 30.84% | 30.82% | 30.82% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 7,536 | 7,249 | 6,925 | 6,668 | 6,433 | 6,293 | 6,268 | 6,252 | 6,232 | 6,084 | 5,962 | 5,847 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Lancy Raphael Barboza | Promoter | 46.27% | 0.00 |
| Anita Lancy Barboza | Promoter | 12.52% | 0.00 |
| Isquare Global Pe Fund Llc | Public | 11.20% | 0.00 |
| Manas Strategic Consultants Private Limited | Promoter | 9.15% | 0.00 |
| Michael N. Castelino | Public | 1.87% | 0.00 |
| Wilfred Sylvester Tauro | Public | 1.79% | 0.00 |
| Janet Sylvia Saldanha | Public | 1.69% | 0.00 |
| Merlyn Veera Castelino | Public | 1.67% | 0.00 |
| Stany Jovin Menezes | Public | 1.26% | 0.00 |
| Alan Lancy Barboza | Promoter | 1.09% | 0.00 |
| Clarus Advisors India Private | Promoter | 0.19% | 0.00 |
Promoters held 69.18% of Flomic Global Logistics at the end of the Jun 2026 quarter, up 0.02 percentage points from 69.16% a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Flomic Global Logistics had 5,847 shareholders at the end of the Jun 2026 quarter, against 6,252 a year earlier.
Isquare Global Pe Fund Llc (Public) held 11.20% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.